< back to list
Videos
Share this video:
Post on twitter:
Special Valuation Series: Valuations in the cleantech industry – MaRS Best Practices
Canada’s biotechnology and cleantech communities have a history of developing world-leading technologies and a reputation for producing some of the best research minds in the world—but for these industries to grow, they must have access to new capital to fund research and development that will allow Canada to maintain its position as a world leader. The problem of a lack of capital is compounded by ever-increasing expectations from investors as to what they expect to see from companies before they consider an investment.
Related Videos
< back to list
















